NIH-funded research R01 grant

Effects of alphavirus infection on muscle health

Official title: Acute and chronic effects on skeletal muscle from alphavirus infection

Funded at University of Utah · NIH-11104034 · Data updated 2026-11-12

This study is looking at how infections from Ross River and Chikungunya viruses can harm your muscles and cause issues like pain and weakness, using mice to learn more about what happens in the body so we can find better ways to help people who are affected.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Utah
NIH-funded
Lab location1 site (Salt Lake City, United States)
Project startMay 15, 2025
Project endApril 30, 2030
Funding year2025
Award (this year)$640,905
NIH project number1R01AR085598-01
Project IDNIH-11104034 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have experienced infections from Ross River or Chikungunya viruses and are suffering from muscle-related symptoms.

Less likely to help

Patients who have not been infected with Ross River or Chikungunya viruses are unlikely to benefit from this research.

What this research studies

This research investigates how infections from Ross River and Chikungunya viruses impact skeletal muscle, leading to conditions like myopathy and chronic pain. By using advanced mouse models and genetic techniques, the team aims to understand the mechanisms behind muscle damage and the body's response to these viral infections. The study will explore both the immediate and long-term effects of these viruses on muscle structure and function, providing insights into potential treatments for affected patients.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for patients suffering from chronic muscle pain and dysfunction caused by viral infections.

How similar studies have gone: Other research has shown promising results in understanding viral impacts on muscle health, but this specific approach is relatively novel.

Where this research is happening

  • University of Utah
    Salt Lake City, United States
    Active

Researchers

  • Principal investigator: Kardon, Gabrielle — University of Utah
  • Study coordinator: Kardon, Gabrielle

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.